Literature DB >> 22530244

Promising new era dawns for cystic fibrosis treatment.

Zöe Corbyn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22530244     DOI: 10.1016/s0140-6736(12)60617-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Subcellular mechanisms in pulmonary arterial hypertension: combinatorial modalities that inhibit anterograde trafficking and cause bone morphogenetic protein receptor type 2 mislocalization.

Authors:  Yang-Ming Yang; Kirk B Lane; Pravin B Sehgal
Journal:  Pulm Circ       Date:  2013-12-04       Impact factor: 3.017

2.  Progress in cystic fibrosis and the CF Therapeutics Development Network.

Authors:  Steven M Rowe; Drucy S Borowitz; Jane L Burns; John P Clancy; Scott H Donaldson; George Retsch-Bogart; Scott D Sagel; Bonnie W Ramsey
Journal:  Thorax       Date:  2012-10       Impact factor: 9.139

3.  Capturing the Direct Binding of CFTR Correctors to CFTR by Using Click Chemistry.

Authors:  Chandrima Sinha; Weiqiang Zhang; Chang Suk Moon; Marcelo Actis; Sunitha Yarlagadda; Kavisha Arora; Koryse Woodroofe; John P Clancy; Songbai Lin; Assem G Ziady; Raymond Frizzell; Naoaki Fujii; Anjaparavanda P Naren
Journal:  Chembiochem       Date:  2015-08-11       Impact factor: 3.164

4.  Overcoming Immunological Challenges to Helper-Dependent Adenoviral Vector-Mediated Long-Term CFTR Expression in Mouse Airways.

Authors:  Huibi Cao; Rongqi Duan; Jim Hu
Journal:  Genes (Basel)       Date:  2020-05-18       Impact factor: 4.096

5.  Generation of Lung Epithelium from Pluripotent Stem Cells.

Authors:  Amy P Wong; Janet Rossant
Journal:  Curr Pathobiol Rep       Date:  2013-04-03

Review 6.  Update on key emerging challenges in cystic fibrosis.

Authors:  Mark T Jennings; Kristin A Riekert; Michael P Boyle
Journal:  Med Princ Pract       Date:  2014-01-10       Impact factor: 1.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.